Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
top-stories

3 min read • September 3, 2024
EXCLUSIVE: Investor Ross Gerber On How Cannabis Rescheduling Could Slash Costs For Companies

3 min read • September 2, 2024
Harris Campaign Slams Donald Trump Over Cannabis Shift: Calls It ‘Brazen Flip-Flop’

3 min read • August 31, 2024
Trump’s Cannabis Endorsement – Marijuana Industry Responds: ‘We Have Two Candidates’ Who Are Pro-Marijuana

3 min read • August 31, 2024
Death Penalty Scheme Gone Wrong: Husband’s Plot To Frame Wife With Cannabis Fails

3 min read • August 31, 2024
Donald Trump Supports Cannabis Legalization in Florida: Game Changer And Huge Blow To Ron DeSantis

2 min read • August 30, 2024
How Louisiana’s Native American Tribes Could Pioneer Legal Cannabis Sales Despite State Bans

2 min read • August 30, 2024
Cannabis Rescheduling Could Reverse ‘Decades Of Misguided Drug Policy,’ Says Key Industry Organization Following DEA Hearing Rescheduling (UPDATED)

3 min read • August 30, 2024
DeSantis Rejects Cannabis Legalization Despite Rising Bipartisan Support, Poll Reveals (UPDATE)

3 min read • August 30, 2024
2 Million Brits Are Self Medicating With Cannabis, The Market Soars 10% Monthly – Will National Health Service Prescriptions Catch Up?

3 min read • August 29, 2024
Ben Stiller Praises Kamala Harris, Has Brought ‘Change’ To Democratic Party; Don Trump Jr. Says No Way; Cannabis Industry Says Yes, Bring Harris-Walz On

4 min read • August 29, 2024
Last Big Cannabis Event Before The Election: 10 Reasons To Attend

2 min read • August 29, 2024
Cannabis Rescheduling: Will It Change The Industry Or Just Prolong The Wait?
Latest Headlines
View All
10 min read • September 2, 2026
Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround
3 min read • September 2, 2026
Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows
2 min read • September 2, 2026
UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share
7 min read • September 2, 2026
Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation
3 min read • September 1, 2026
Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed
8 min read • September 1, 2026
BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future
2 min read • September 1, 2026
House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown
3 min read • September 1, 2026
Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split
13 min read • September 1, 2026
Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal
6 min read • September 1, 2026
Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.
4 min read • August 31, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2
5 min read • August 31, 2026
Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis clubs
cannabis cultivation
cannabis earnings
cannabis farms
cannabis study
CBD
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
germany cannabis
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
hemp rules
Hot
IgniteIt Events
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
WNBA
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.
